Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Table 5
Multivariate analysis of progression free survival and overall survival in female never-smokers aged ≤ 65 with ECOG PS 0–1 at diagnosis.